Want to join the conversation?
$REGN said in full-year 2016 it expects EYLEA US net product sales to be up 20-25% over 2015. Sanofi reimbursement of Regeneron commercialization-related expenses are expected to be $320-370MM in 2016. CapEx is expected to be in the range of $550-625MM, down from the previous range of $580-680MM.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.